People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dragonfly Endoscopy Inc. | — | Other Health Care | Series A | $12.7M | $142.0M | 2022 |
| Origin Endoscopy Inc. | — | Biotechnology | Seed | $2.3M | $10.1M | 2024 |
John Wynne at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Wynne on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeremy Starkweather | 2 | 4 |
| Jason Ylizarde | 2 | 2 |
| Jason Grimes | 1 | 3 |
| Michael Freeman | 1 | 2 |
| Stephen Hoag | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.